NEW HOPE, Pa., March 06, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to ...
One of the central themes of the 23rd Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology was device therapy, and, more specifically, the use of biventricular ...
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Receive the the ...
Children with congenital complete atrioventricular block often require lifelong pacemaker therapy. Although such therapy restores a normal heart rate, it also results in dyssynchronous left ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results